Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/365150


Opportunities for Proteomics Technology Markets in Europe


Description: Low Return on Investment that can Dissuade Potential Entrants in Proteomics Technology Markets Offset by Increasing Public Funding
Proteomic research requires huge capital investments and currently, yields poor revenues. Companies, therefore, infer that the market lifecycle is at a stage where they need to wait before witnessing profits. In addition, pharmaceutical companies are doubtful about adopting this new technology in their drug development pipeline as they are wary of premium pricing. However, public funding institutions are giving importance to this growing biological discipline next to comparative genomics. The proteomics market is considered an emerging area with immense potential. In fact, Governments and federal ministries in the three major countries, namely the United Kingdom, France and Germany, are allocating thematic priorities to nurture the growth of this market. This is likely to result in greater industrialization of this field, which in turn, will boost the confidence of companies to invest in this fast-paced and dynamic arena.

This

Additional Information

Technological Innovation to Propel the Proteomics Market
"The increasing relevance of protein-protein interactions and protein analytics in drug discovery as well as clinical diagnostics has highlighted the importance of proteome research," says the analyst of this study. "The technological shift towards proteome research following the completion of the Human Genome Project combined with technological innovations of instruments is likely to increase the significance of proteome research."
Technological advancements in protein separation technologies and two-dimensional gel electrophoresis are likely to usher in a ubiquitous approach to assess differential protein expressions. Maximum utility of expression proteomics tools in the target discovery phase of drug development is likely to trigger reliable separation and identification of low abundant proteins with poor expression levels. Moreover, the development of matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) technologies has enlarged the scope of building versatile mass spectrometers, considered the cornerstone of proteomics. The improved mass spectrometers are likely to have enhanced functionalities of automation and compatibility with other proteomics equipment. Another possible trend is the emergence of newer dyes that increase the chances for improved sensitivity.

New Applications Using Proteomics Fostered by Public-private Partnerships
The high impact of emerging technologies such as proteomics is causing radical changes in the fields of drug discovery as well as clinical research and diagnostics. As a result, end users in the European life sciences arena are looking for a complete, integrated solution. The current trend in the markets has been the formation of broad partnerships, as the commercial sector realises that this is one of the best ways of maximizing opportunities in this area since smaller companies can affiliate themselves with larger, more recognized suppliers.
"Besides those between companies, another important collaboration is between companies and academic research units, since such alliances are likely to be potentially very interesting as they are anticipated to be a merger of disciplines," notes the analyst. "This ensures that academic research develops groundbreaking research methodologies, while companies can introduce the technology into possible applications that are likely to boost their business in terms of revenues and in this manner, the uptake of proteomics tools can be encouraged."


Contents: 1. Executive Summary
- 1. Industry Snapshot
- - 1. Executive Summary

2. Glossary
- 1. Glossary of Terms
- - 1. Glossary
- 2. Exchange Rates
- - 1. Exchange Rates

3. Total Market
- 1. Market Overview
- - 1. Market Overview and Definition
- 2. Segmentation
- - 1. Segmentation
- 3. Market Engineering Measurements
- - 1. Market Engineering Measurements
- 4. Market Drivers
- - 1. Drivers- a. Increased Funding from Both Public and Private Research Bodies for R&D Expenditure- b. One of the Principal Factors that Drive the Proteomics Market Forward is Technological Innovation- c. Genomic Sequence Completion Fuels the Growth of the Emerging Proteomics Technology Market
- 5. Industry Challenges
- - 1. Industry Challenges
- 6. Total European Revenue Forecasts
- - 1. Revenue Forecasts
- 7. End-user Segmentation
- - 1. End-user Trends
- 8. Technology Trends
- - 1. Technology Trends
- 9. Competitive Landscape
- - 1. Competitive Structure
- 10. Funding Landscape-Germany
- - 1. Funding Landscape
- 11. Funding Landscape -United Kingdom
- - 1. Funding Scenario

4. Protein Separation Technology
- 1. Introduction
- - 1. Background
- 2. Market Engineering Measurements
- - 1. Market Engineering Measurements
- 3. Revenue Forecasts
- - 1. Revenue Forecasts

5. Protein Identification Technology
- 1. Background
- - 1. Overview
- 2. Market Engineering Measurements
- - 1. Market Engineering Measurements
- 3. Revenue Forecasts
- - 1. Revenue Forecasts

6. Frost & Sullivan Awards
- 1. Awards
- - 1. Frost & Sullivan Award Description-European Proteomics Technology Market
- 2. Frost & Sullivan Product Line Strategy Award
- - 1. Award Description
- 3. Frost & Sullivan Product Innovation Award
- - 1. Award Description

7. Strategic Recommendations
- 1. Strategic Recommendations
- - 1. Possible Strategies

8. DSD for Proteomics
- 1. Private Investment for Biotechnology
- - 1. Private Investment in Biotechnology
- 2. Pharmaceutical R&D Expenditure
- - 1. Pharmaceutical R&D Expenditure
- 3. Biotech Companies and Number of Employees
- - 1. Biotech Companies
- - 2. Number of Employees
- 4. Pharmaceutical R&D Expenditure as a percentage of the Pharmaceutical Market
- - 1. Pharmaceutical R&D Expenditure as a Percent of Pharmaceutical Market

9. Database of key Industry Participants(DKIP)
- 1. Database of Key Industry Participants
- - 1. Database of Key Industry Participants




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/365150

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 02/12/2008 21:32:21
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Opportunities for Proteomics Technology Markets in Europe
Web Address:
http://www.researchandmarkets.com/reports/365150
Office Code:
OCIFHIQMUOX

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Enterprisewide €5,120.00
Electronic and Hard Copy (PDF) - Enterprisewide €5,517.00 + EUR€ 50.00 Shipping/Handling *

* Shipping/Handling is only charged once per order.


Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 02/12/2008 21:32:21

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World